AGON’s Post

Mohamed Abu Shawish, Cluster General Manager GCC at KKI, shared his thoughts with BioSpectrum Asia about the growing pharmaceutical sector in the Middle East region. Increased government spending and public-private partnerships are driving the region to become a biotech powerhouse, led by the Kingdom of Saudi Arabia, the United Arab Emirates and Qatar. Learn more about this fast-paced, evolving pharmaceutical sector and why companies like KKI are expanding their operations in the region below: https://lnkd.in/eVbB9T9i

The Middle East is set to witness the unrivalled force of the pharmaceutical sector as it hosts the 6th Arab Pharma Manufacturers Expo’ the region's largest & premier exhibition on comprehensive Pharma Manufacturing. Mark your calendars for July 2nd and 3rd, 2024, as this dynamic event descends upon the JIEC - Jordan International Exhibition Center at the iconic MECCA MALL in Amman, Jordan. Prepare to be part of history as we present the largest and most impactful edition to date, showcasing the pinnacle of industry advancements and innovations. #sustainablepackaging #recyclability #packaging #sustainability #circulareconomy #recycledmaterials #resourceefficiency #pharmaceuticalpackaging

🍽 On May 28 #ProximaResearch organized a business lunch in Uzbekistan! 👥 Participants explored the capabilities of #MarketAudit, gained fresh insights into pharmaceutical markets in Europe and the US, and analyzed the promotional activities of pharma brands in Uzbekistan using data from the #PromoTest project ✨ You can watch the video to capture the atmosphere of the event: https://t1p.de/xmubh 💭 Would you be interested in seeing the speakers' presentations? Leave a " " in the comments!

Valuable insights from co-speakers from the MENA and APAC regions!

KELIX bio, an emerging markets-focused specialty #generic #biopharmaceutical company is looking to acquire five #UAE-based #pharma entities to further expand its product portfolio of affordable critical drugs, and scale growth. The deals would likely follow the enforcement of the Dubai-headquartered Company’s acquisition by Abu Dhabi’s sovereign investor Mubadala Investment Company, announced in March. Set up in 2020 by #Africa-focused investor Development Partners International (DPI), UK’s development finance institution British International Investment, EBRD, and executives Hocine Sidi-Said and Alhadi Alwazir, KELIX bio develops and commercializes affordable specialty products for underserved populations across emerging markets. Read on to catch details about the proposed #deals on VCCircle. Dilasha Seth reports Hocine Sidi-Said Alhadi Alwazir Dr. Bakheet Al Katheeri ADWIA Pharmaceuticals Celon Laboratories Limited KELIX bio Malta PHI By Kelix bio Gulf Inject Yas Holding Bioventure Bioventure Healthcare Wellpharma Medical Solutions #sovereignwealthfund #pharma #acquisition #gulfbusiness #africanbusiness #africanhealthcare #genericdrugs #deals #uaebusiness #emergingmarkets #growth #abudhabi https://lnkd.in/g2wGh4V9

Safe Medicines have two parents…regulators and industry. So what training you give to one side, you should give to the other. Today is Day 1 of training for #industry for Dissolution and PVT by The United States Pharmacopeial Convention, Inc. supported by Tshwane University of Technology Chair in Pharmaceutical & Biotech Advancement in Africa and Stargate Scientific. We have over 10 companies and 24 delegates attending from all over #Africa. It’s great to see African #companies investing in improved quality and safety of their products. #local pharmaceutical manufacturing #manufacturing in Africa #LPP #MIA

📌 On September 26-28, 2023, the 4th Eurasian Pharmaceutical Summit 2023 was held in #Samarkand in a hybrid format, in which more than 400 representatives of pharmaceutical companies operating in the markets of Central #Asia, the #Caucasus and Eastern #Europe annually participate. Within the framework of the Summit, a program of 20 sessions was planned on issues of regulatory #policy, #government #procurement, #sales, #marketing and #production of #medicines. #Development trends in pharmaceutical markets in the countries of Central Asia, the Caucasus and Eastern Europe: #Kazakhstan, #Uzbekistan, #Kyrgyzstan, #Belarus, #Armenia, #Azerbaijan, #Tajikistan, #Turkmenistan, #Georgia, #Moldova and #Mongolia were also discussed. Partners of GRATA International Almaty office Shakhrukh Usmanov and Aliya Zhumekenova participated as delegates of the event. 🔗 More details can be found on the Summit website →

Just added to the WAITRO website, a report on the market introduction webinar that the Secretariat hosted late last November: Cross-Border Markets for Innovation: Biopharmaceutical Regulations in Africa. We hope this will be the start of an ongoing series in cross-border markets that will help both our RTO members and our industrial associate members access new markets for their innovation. This is a new idea for WAITRO, so we have to go up a learning curve. We know, for example, that there were bandwidth problems for some of our African partners that made them hard to understand and we are also aware of the need to broaden the international diversity of companies looking for opportunities. These things are always a coalition of the willing, so if you have an idea how we should proceed, please get in touch and help us plan the next market-oriented event in your area of #innovation or your geographical area! #WAITRO #OpenInnovation #Ideas #Partnership #Together2030 #SDGs #ClimateChange #Impact #GlobalInnovationFamily #Connect #Matchmaking #Empowerment Bathabile Ramalapa Jenny-Lee Panayides adane demeke moloro Council for Scientific and Industrial Research (CSIR) Nanjing Sanhome Pharmaceutical Co., Ltd. SUZHONG Pharmaceutical Limited Group Jiangsu Aidea Pharmaceutical Co., Ltd. SAIRA

On the occasion of BIO-EUROPE 2023 💊, which will be held in Munich, KGCCI (AHK Korea) and the KPMBA (Korea Pharmaceutical and Bio-Pharma Manufacturers Association) are co-hosting the ‘Korea-EU Networking Night 🌐’ at Novotel Munich Messe on November 7 from 6 pm to 8 pm CET. As of 2021, the Korean pharmaceutical market was valued at around $22.2 billion, with innovative Korean companies having developed 36 new drugs to date. Korea’s commitment to innovation extends beyond this achievement, as Korean companies now have 1,833 new drug pipelines, all in pursuit of creating more groundbreaking drugs. Furthermore, Korea consistently fosters global collaborations through open innovation, connecting with global pharmaceutical companies, universities, research institutes, and more, with an aim of establishing a robust worldwide network. 🌍 Please join us for an evening of fruitful conversations and enriched networking with globally recognized partners from Korea. Click on the link to register now: https://lnkd.in/gSCbqRTn ✨ #KGCCI #AHKKorea #Korea #Germany #BIOEurope2023 #PharmaceuticalInnovation #BioPharma #KPMBA #NetworkingNight #Munich #BioTech #PharmaceuticalIndustry #OpenInnovation #Healthcare #NetworkingEvent #PartnerforKoreanGermanBusiness #PartnerforGermanyandKorea #PartnerforSuccess